Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Hua Huang

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Oncotarget|December 10, 2017
The prognostic significance of celiac lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapyYen-Hao Chen, Hung-I Lu, Yu-Ming Wang, et al.
Plos One|January 12, 2017
Novel Inflammation-Based Prognostic Score for Predicting Survival in Patients with Metastatic Urothelial CarcinomaYu-Li Su, Meng-Che Hsieh, Po-Hui Chiang, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 26, 2014
Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinomaYen-Hao Chen, Cheng-Hua Huang, Hung-I Lu, et al.
Oncology|December 4, 2019
Comparative Study of the Safety and Efficacy of First-Line Cisplatin and Carboplatin Chemotherapy in Elderly Patients with Metastatic Urothelial CarcinomaShih-Yu Huang, Chia-Che Wu, Meng-Che Hsieh, et al.
BMC Cancer|November 9, 2016
Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitorsYu-Mu Chen, Chien-Hao Lai, Kun-Ming Rau, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitorsYu-Mu Chen, Chien-Hao Lai, Kun-Ming Rau, et al.
International Journal of Antimicrobial Agents|December 17, 2008
Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocciShih-Ming Tsao, Hsiu-Chen Lin, Chun-Ming Lee, et al.
International Journal of Antimicrobial Agents|December 17, 2008
In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in TaiwanJien-Wei Liu, Lih-Shinn Wang, Yu-Jen Cheng, et al.
International Journal of Antimicrobial Agents|December 17, 2008
In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methodsChun-Hsing Liao, Hsiang-Chi Kung, Gwo-Jong Hsu, et al.
International Journal of Antimicrobial Agents|December 17, 2008
Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing EnterobacteriaceaeChin-Te Lu, Yin-Ching Chuang, Wu Sun, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Oncotarget|December 10, 2017
The prognostic significance of celiac lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapyYen-Hao Chen, Hung-I Lu, Yu-Ming Wang, et al.
Plos One|January 12, 2017
Novel Inflammation-Based Prognostic Score for Predicting Survival in Patients with Metastatic Urothelial CarcinomaYu-Li Su, Meng-Che Hsieh, Po-Hui Chiang, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 26, 2014
Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinomaYen-Hao Chen, Cheng-Hua Huang, Hung-I Lu, et al.
Oncology|December 4, 2019
Comparative Study of the Safety and Efficacy of First-Line Cisplatin and Carboplatin Chemotherapy in Elderly Patients with Metastatic Urothelial CarcinomaShih-Yu Huang, Chia-Che Wu, Meng-Che Hsieh, et al.
BMC Cancer|November 9, 2016
Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitorsYu-Mu Chen, Chien-Hao Lai, Kun-Ming Rau, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitorsYu-Mu Chen, Chien-Hao Lai, Kun-Ming Rau, et al.
International Journal of Antimicrobial Agents|December 17, 2008
Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocciShih-Ming Tsao, Hsiu-Chen Lin, Chun-Ming Lee, et al.
International Journal of Antimicrobial Agents|December 17, 2008
In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in TaiwanJien-Wei Liu, Lih-Shinn Wang, Yu-Jen Cheng, et al.
International Journal of Antimicrobial Agents|December 17, 2008
In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methodsChun-Hsing Liao, Hsiang-Chi Kung, Gwo-Jong Hsu, et al.
International Journal of Antimicrobial Agents|December 17, 2008
Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing EnterobacteriaceaeChin-Te Lu, Yin-Ching Chuang, Wu Sun, et al.
Pageof 6